Shinobu Tsuzuki
Nagakute, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications
Nintedanib inhibits the VEGFR-ERK signaling pathway in human KRAS-mutated cancer cells.
Journal: Cell death & disease
Published: January 20, 2026
Characterization of targeted knock-in achieved via tandem paired nicking mediated by CRISPR/Cas9 nickases.
Journal: Methods (San Diego, Calif.)
Published: February 27, 2025
Targeting fatty acid synthase suppresses tumor development in NF2/CDKN2A-deficient pleural mesothelioma.
Journal: Cell death & disease
Published: February 11, 2025
Two-way inhibition of PAX5 transcriptional activity by PAX5::CBFA2T3.
Journal: FEBS open bio
Published: January 24, 2025
NUP98-BPTF promotes oncogenic transformation through PIM1 upregulation.
Journal: Cancer medicine
Published: January 19, 2024
RGS1 and CREB5 are direct and common transcriptional targets of ZNF384-fusion proteins.
Journal: Cancer medicine
Published: January 18, 2024
ARK5 enhances cell survival associated with mitochondrial morphological dynamics from fusion to fission in human multiple myeloma cells.
Journal: Cell death discovery
Published: June 22, 2023
EBF1-JAK2 inhibits the PAX5 function through physical interaction with PAX5 and kinase activity.
Journal: International journal of hematology
Published: December 25, 2022
CAMK2D: a novel molecular target for BAP1-deficient malignant mesothelioma.
Journal: Cell death discovery
Published: December 05, 2022
Last Updated: 09/26/2026